Lumos Pharma Inc reports results for the quarter ended in December - Earnings Summary

Lumos Pharma

11/03/2022 12:14

* Lumos Pharma Inc  LUMO.OQ  reported a quarterly adjusted
loss
of 67 cents​​ per share for the quarter ended in December. The
mean expectation of six analysts for the quarter was for a loss
of 92 cents per share.
    * Revenue rose 450% to $220.00 thousand from a year ago; 
analysts
expected zero. 
    * Lumos Pharma Inc's reported EPS for the quarter was a loss
of 67
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Lumos Pharma Inc shares had risen by 37.4% this quarter.
    * The company reported a quarterly loss of $5.64 million.
    * Wall Street's median 12-month price target for Lumos
Pharma Inc
is $25.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 11 at 12:13 p.m.  ​All
figures in US dollars unless otherwise stated